[HTML][HTML] Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver
M Ganz, T Csak, B Nath, G Szabo - World journal of …, 2011 - ncbi.nlm.nih.gov
M Ganz, T Csak, B Nath, G Szabo
World journal of gastroenterology: WJG, 2011•ncbi.nlm.nih.govAIM: To examine the activation of the Nalp3 inflammasome and its downstream targets
following lipopolysaccharide (LPS)-induced stimulation in the liver. METHODS: Six-to-eight-
week-old C57BL/6 chow fed mice were injected intraperitoneally with 0.5 μg/g bodyweight
LPS and sacrificed 2, 4, 6, 18 or 24 h later. LPS-induced liver damage was confirmed by a
biochemical assay to detect alanine aminotransferase (ALT) levels. To determine if LPS
stimulation in the liver led to activation of the inflammasome, real-time quantitative …
following lipopolysaccharide (LPS)-induced stimulation in the liver. METHODS: Six-to-eight-
week-old C57BL/6 chow fed mice were injected intraperitoneally with 0.5 μg/g bodyweight
LPS and sacrificed 2, 4, 6, 18 or 24 h later. LPS-induced liver damage was confirmed by a
biochemical assay to detect alanine aminotransferase (ALT) levels. To determine if LPS
stimulation in the liver led to activation of the inflammasome, real-time quantitative …
Abstract
AIM: To examine the activation of the Nalp3 inflammasome and its downstream targets following lipopolysaccharide (LPS)-induced stimulation in the liver.
METHODS: Six-to-eight-week-old C57BL/6 chow fed mice were injected intraperitoneally with 0.5 μg/g bodyweight LPS and sacrificed 2, 4, 6, 18 or 24 h later. LPS-induced liver damage was confirmed by a biochemical assay to detect alanine aminotransferase (ALT) levels. To determine if LPS stimulation in the liver led to activation of the inflammasome, real-time quantitative polymerase chain reaction was used to evaluate the mRNA expression of components of the Nalp3 inflammasome. Enzyme-linked immunosorbent assays were used to determine the protein expression levels of several downstream targets of the Nalp3 inflammasome, including caspase-1 and two cytokine targets of caspase-1, interleukin (IL)-1β and IL-18.
RESULTS: We found that LPS injection resulted in liver damage as indicated by elevated ALT levels. This was associated with a significant increase in both mRNA and protein levels of the proinflammatory cytokine tumor necrosis factor (TNF)-α in the liver, as well as increased levels of TNFs in serum. We showed that LPS stimulation led to upregulation of mRNA levels in the liver for all the receptor components of the inflammasome, including Nalp3, Nalp1, pannexin-1 and the adaptor molecule apoptosis-associated speck-like, caspase recruitment domain-domain containing protein. We also found increased levels of mRNA and protein for caspase-1, a downstream target of the inflammasome. In addition, LPS challenge led to increased levels of both mRNA and protein in the liver for two cytokine targets of caspase-1, IL-1β and IL-18. Interestingly, substantial baseline expression of pre-IL-1β and pre-IL-18 was found in the liver. Inflammasome and caspase-1 activation was indicated by the significant increase in the active forms of IL-1β and IL-18 after LPS stimulation.
CONCLUSION: Our results show that the Nalp3 inflammasome is upregulated and activated in the liver in response to LPS stimulation.
ncbi.nlm.nih.gov